XML 73 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions Acquisitions (Details 1) (USD $)
Mar. 31, 2015
Dec. 31, 2014
Feb. 12, 2015
Business Acquisition [Line Items]      
Goodwill $ 1,849,852,000us-gaap_Goodwill $ 1,760,249,000us-gaap_Goodwill  
Convergence Pharmaceuticals      
Business Acquisition [Line Items]      
In-process research and development and other intangible assets     424,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
/ us-gaap_BusinessAcquisitionAxis
= biib_ConvergencePharmaceuticalsMember
Other intangible assets     7,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= biib_ConvergencePharmaceuticalsMember
Goodwill     92,300,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= biib_ConvergencePharmaceuticalsMember
Deferred tax liability     (84,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= biib_ConvergencePharmaceuticalsMember
Other, net     (1,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= biib_ConvergencePharmaceuticalsMember
Total purchase price     $ 438,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= biib_ConvergencePharmaceuticalsMember